LU78363A1 - - Google Patents

Info

Publication number
LU78363A1
LU78363A1 LU78363A LU78363A LU78363A1 LU 78363 A1 LU78363 A1 LU 78363A1 LU 78363 A LU78363 A LU 78363A LU 78363 A LU78363 A LU 78363A LU 78363 A1 LU78363 A1 LU 78363A1
Authority
LU
Luxembourg
Application number
LU78363A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU78363A1 publication Critical patent/LU78363A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU78363A 1976-10-22 1977-10-21 LU78363A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB44008/76A GB1561345A (en) 1976-10-22 1976-10-22 8 - azapuring - 6 - ones

Publications (1)

Publication Number Publication Date
LU78363A1 true LU78363A1 (fr) 1978-06-12

Family

ID=10431345

Family Applications (1)

Application Number Title Priority Date Filing Date
LU78363A LU78363A1 (fr) 1976-10-22 1977-10-21

Country Status (15)

Country Link
US (1) US4167568A (fr)
JP (1) JPS5395993A (fr)
AU (1) AU510478B2 (fr)
BE (1) BE859987A (fr)
CA (1) CA1111027A (fr)
CH (1) CH628898A5 (fr)
DE (1) DE2747199A1 (fr)
DK (1) DK142766B (fr)
GB (1) GB1561345A (fr)
HU (1) HU180009B (fr)
IE (1) IE45810B1 (fr)
LU (1) LU78363A1 (fr)
NL (1) NL7711332A (fr)
SE (1) SE7711836L (fr)
ZA (1) ZA776258B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
NZ504436A (en) 1997-11-12 2001-08-31 Bayer Ag 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
JP4540295B2 (ja) * 2001-05-09 2010-09-08 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト ２−フェニル置換イミダゾトリアジノンの新しい用途
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
TWI845600B (zh) 2019-01-24 2024-06-21 美商普羅米修斯生物科學股份有限公司 Gpr35調節劑
CA3186635A1 (fr) * 2020-07-23 2022-01-27 Robert Higuchi Agents therapeutiques ciblant gpr35

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819631A (en) * 1970-12-15 1974-06-25 May & Baker Ltd Azapurinones
GB1493685A (en) * 1970-12-15 1977-11-30 May & Baker Ltd 8-azapurinones
GB1421970A (en) * 1973-06-12 1976-01-21 May & Baker Ltd 8-azapurin-6-one derivatives
US4052390A (en) * 1973-06-12 1977-10-04 May & Baker Limited Azapurinones

Also Published As

Publication number Publication date
GB1561345A (en) 1980-02-20
CH628898A5 (fr) 1982-03-31
DE2747199A1 (de) 1978-04-27
DK142766C (fr) 1981-08-17
HU180009B (en) 1983-01-28
DK142766B (da) 1981-01-19
NL7711332A (nl) 1978-04-25
ZA776258B (en) 1978-07-26
AU510478B2 (en) 1980-06-26
CA1111027A (fr) 1981-10-20
JPS5395993A (en) 1978-08-22
IE45810L (en) 1978-04-22
SE7711836L (sv) 1978-04-23
BE859987A (fr) 1978-04-21
IE45810B1 (en) 1982-12-01
US4167568A (en) 1979-09-11
AU2991177A (en) 1979-04-26
DK467177A (fr) 1978-04-23

Similar Documents

Publication Publication Date Title
CH630216GA3 (fr)
DK142766C (fr)
JPS543918B2 (fr)
JPS5513577B2 (fr)
JPS5372781U (fr)
JPS5647795Y2 (fr)
JPS51118767U (fr)
JPS5349940U (fr)
JPS52152255U (fr)
JPS52134018U (fr)
JPS52124191U (fr)
DD123524A1 (fr)
CH609583A5 (fr)
BG23361A1 (fr)
BG23266A1 (fr)
CH587399A5 (fr)
DD125107A1 (fr)
DD124938A1 (fr)
DD124429A1 (fr)
DD123971A1 (fr)
DD123828A1 (fr)
CH599191A5 (fr)
CH591224A5 (fr)
BG23248A1 (fr)
CH614297A5 (fr)